tiprankstipranks
Trending News
More News >
MeaTech 3D Ltd. (MTTCF)
OTHER OTC:MTTCF
US Market

MeaTech 3D (MTTCF) AI Stock Analysis

Compare
22 Followers

Top Page

MTTCF

MeaTech 3D

(OTC:MTTCF)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
$0.01
▲(0.00% Upside)
Action:UpgradedDate:12/30/25
The score is driven primarily by very weak financial performance (minimal revenue, large losses, and significant cash burn alongside multi-year balance-sheet erosion). Valuation provides limited support due to negative earnings and no dividend data, while technical assessment is constrained by missing indicators and an extremely high beta suggesting outsized volatility risk.
Positive Factors
Innovative Business Model
MeaTech 3D's focus on cultured meat production positions it at the forefront of sustainable food tech, offering potential for long-term growth as demand for ethical and environmentally friendly meat alternatives increases.
Strategic Partnerships
By partnering with established food industry players, MeaTech 3D can accelerate the commercialization and adoption of its technologies, potentially leading to increased market penetration and revenue growth.
Sustainable Industry Trend
The company's alignment with the growing trend towards sustainability in food production provides a durable competitive advantage as consumers increasingly seek environmentally friendly options.
Negative Factors
Weak Financial Performance
MeaTech 3D's minimal revenue and significant losses highlight operational inefficiencies and financial instability, which could hinder its ability to invest in growth and innovation over the long term.
Heavy Reliance on External Financing
Dependence on external financing for cash flow needs poses a risk to financial stability, potentially limiting the company's strategic flexibility and increasing vulnerability to market fluctuations.
Declining Financial Stability
A declining equity ratio indicates deteriorating financial stability, which could impact the company's ability to secure favorable financing terms and invest in future growth opportunities.

MeaTech 3D (MTTCF) vs. SPDR S&P 500 ETF (SPY)

MeaTech 3D Business Overview & Revenue Model

Company DescriptionMeaTech 3D Ltd., a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter. The company develops a three-dimensional bioprinter to deposit layers of differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. It intends to license its production technology; provide associated products, such as cell lines, printheads, bioreactors, and incubators; and offer services, such as technology implementation, training, and engineering support directly and through contractors to food processing and food retail companies. The company is headquartered in Rehovot, Israel.
How the Company Makes MoneyMeaTech 3D Ltd. generates revenue primarily through the development and licensing of its cultured meat production technologies. The company seeks to collaborate with food producers and distributors by offering its proprietary bioprinting and cell cultivation technologies, enabling partners to produce cultured meat products. Revenue streams include technology licensing fees, research and development partnerships, and potential future sales of cultured meat products directly to consumers or through wholesale channels. The company may also engage in strategic partnerships with established food industry players to accelerate the commercialization and adoption of its technologies.

MeaTech 3D Financial Statement Overview

Summary
Financials are extremely weak: negligible revenue ($10K in 2024), negative gross profit, and very large net losses (~$8.5M). Cash burn remains heavy (FCF about -$9.4M). While losses and cash outflows improved vs. 2023, the balance sheet has eroded sharply over time (equity down to ~$4.0M from ~$37.6M in 2021), implying elevated ongoing funding/dilution risk.
Income Statement
6
Very Negative
The company remains in a very weak earnings position, with minimal revenue ($10K in 2024 vs. $0 in prior years) and deeply negative profitability. 2024 gross profit is negative (-$12K), and losses remain extremely large (net loss of ~$8.5M), indicating the current cost structure is far above the revenue base. While the net loss improved versus 2023 (about -$16.9M), the business is still far from demonstrating a scalable, profitable operating model.
Balance Sheet
28
Negative
Leverage is moderate with debt at ~$2.5M against equity of ~$4.0M in 2024 (debt-to-equity ~0.61), but the equity base has declined sharply over time (from ~$37.6M in 2021 to ~$4.0M in 2024), reflecting sustained losses and balance-sheet erosion. Total assets also contracted materially (to ~$7.8M in 2024 from ~$40.7M in 2021). Returns to shareholders are deeply negative (return on equity about -2.1 in 2024), which raises ongoing dilution/financing risk if losses persist.
Cash Flow
10
Very Negative
Cash burn remains heavy, with operating cash flow of about -$8.5M and free cash flow of about -$9.4M in 2024, following similarly negative results in prior years. There is an improvement versus 2023 (less negative operating and free cash flow), but the company is still consistently consuming cash rather than generating it. Cash flow is negative at a level that appears difficult to support without continued external funding.
BreakdownTTMDec 2024Dec 2023Mar 2023Dec 2021Dec 2020
Income Statement
Total Revenue10.00K10.00K0.000.000.000.00
Gross Profit-12.00K-12.00K-450.83K-382.50K-680.47K-214.49K
EBITDA-7.03M-8.01M-13.69M-25.72M-17.33M-18.58M
Net Income-8.03M-8.52M-16.86M-21.77M-18.04M-18.53M
Balance Sheet
Total Assets5.86M7.79M10.82M15.32M40.65M17.47M
Cash, Cash Equivalents and Short-Term Investments1.43M1.36M4.60M6.42M19.33M13.71M
Total Debt874.00K2.46M2.81M3.35M411.00K180.00K
Total Liabilities1.75M3.74M4.94M7.43M3.03M1.84M
Stockholders Equity4.11M4.05M5.88M9.40M37.62M15.63M
Cash Flow
Free Cash Flow-7.61M-9.44M-13.00M-17.24M-15.79M-4.51M
Operating Cash Flow-6.90M-8.46M-12.73M-14.31M-13.96M-3.83M
Investing Cash Flow-2.04M-956.00K-764.00K-3.53M-9.34M-1.88M
Financing Cash Flow4.76M6.38M11.26M5.57M29.02M17.34M

MeaTech 3D Risk Analysis

MeaTech 3D disclosed 56 risk factors in its most recent earnings report. MeaTech 3D reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

MeaTech 3D Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
52
Neutral
$31.47M-16.42-14.63%17.73%-34.71%
48
Neutral
$5.07M-0.23-84.22%-81.88%-672.01%
46
Neutral
$328.25M-10.17%24.25%
46
Neutral
$4.98M
43
Neutral
$1.90M-0.53-135.23%
40
Underperform
$1.90M-0.02-136.13%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MTTCF
MeaTech 3D
0.01
0.00
0.00%
BYND
Beyond Meat
0.82
-2.36
-74.21%
SOWG
Sow Good
0.46
-2.00
-81.26%
LSF
Laird Superfood
2.86
-3.14
-52.33%
STKH
Steakholder Foods
1.41
-57.79
-97.62%
HCWC
Healthy Choice Wellness Corp. Class A
0.33
-0.25
-42.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025